Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'APL' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 164 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Raulin, J
      Human immunodeficiency virus and host cell lipids. Interesting pathways inresearch for a new HIV therapy

      PROGRESS IN LIPID RESEARCH
    2. Lam, MSH; Ignoffo, RJ
      Arsenic trioxide for the treatment of acute promyelocytic leukemia

      CANCER PRACTICE
    3. Takeshita, A; Shigeno, K; Shinjo, K; Naito, K; Ohnishi, K; Hayashi, H; Tanimoto, M; Ohno, R
      All-trans retinoic acid (ATRA) differentiates acute promyelocytic leukemiacells independently of P-glycoprotein (P-gp) related multidrug resistance

      LEUKEMIA & LYMPHOMA
    4. Estey, E; Koller, C; Cortes, J; Reed, P; Freireich, E; Giles, F; Kantarjian, H
      Treatment of newly-diagnosed acute promyelocytic leukemia with liposomal all-trans retinoic acid

      LEUKEMIA & LYMPHOMA
    5. Zhang, TD; Chen, GQ; Wang, ZG; Wang, ZY; Chen, SJ; Chen, Z
      Arsenic trioxide, a therapeutic agent for APL

      ONCOGENE
    6. Cassinat, B; Chomienne, C
      Biological features of primary APL blasts: their relevance to the understanding of granulopoiesis, leukemogenesis and patient management

      ONCOGENE
    7. Benoit, G; Roussel, M; Pendino, F; Segal-Bendirdjian, E; Lanotte, M
      Orchestration of multiple arrays of signal cross-talk and combinatorial interactions for maturation and cell death: another vision of t(15;17) preleukemic blast and APL-cell maturation

      ONCOGENE
    8. Lin, RJ; Sternsdorf, T; Tini, M; Evans, RM
      Transcriptional regulation in acute promyelocytic leukemia

      ONCOGENE
    9. Piazza, F; Gurrieri, C; Pandolfi, PP
      The theory of APL

      ONCOGENE
    10. Regad, T; Chelbi-Alix, MK
      Role and fate of PML nuclear bodies in response to interferon and viral infections

      ONCOGENE
    11. Roussel, MJS; Lanotte, M
      Maturation sensitive and resistant t(15;17) NB4 cell lines as tools for APL physiopathology: nomenclature of cells and repertory of their known genetic alterations and phenotypes

      ONCOGENE
    12. Pandolfi, PP
      In vivo analysis of the molecular genetics of acute promyelocytic leukemia

      ONCOGENE
    13. Pandolfi, PP
      Transcription therapy for cancer

      ONCOGENE
    14. Muto, A; Kizaki, M; Kawamura, C; Matsushita, H; Fukuchi, Y; Umezawa, A; Yamada, T; Hata, J; Hozumi, N; Yamato, K; Ito, M; Ueyama, Y; Ikeda, Y
      A novel differentiation-inducing therapy for acute promyelocytic leukemia with a combination of arsenic trioxide and GM-CSF

      LEUKEMIA
    15. Tobal, K; Moore, H; Macheta, M; Yin, JAL
      Monitoring minimal residual disease and predicting relapse in APL by quantitating PML-RAR alpha transcripts with a sensitive competitive RT-PCR method

      LEUKEMIA
    16. Shen, Y; Shen, ZX; Yan, H; Chen, J; Zeng, XY; Li, JM; Li, XS; Wu, W; Xiong, SM; Zhao, WL; Tang, W; Wu, F; Liu, YF; Niu, C; Wang, ZY; Chen, SJ; Chen, Z
      Studies on the clinical efficacy and pharmacokinetics of low-dose arsenic trioxide in the treatment of relapsed acute promyelocytic leukemia: a comparison with conventional dosage

      LEUKEMIA
    17. Gameiro, P; Vieira, S; Carrara, P; Silva, AL; Diamond, J; de Sousa, AB; Mehta, AB; Prentice, HG; Guimaraes, JE; Hoffbrand, AV; Foroni, L; Parreira, A
      The PML-RAR alpha transcript in long-term follow-up of acute promyelocyticleukemia patients

      HAEMATOLOGICA
    18. Motsouka, P; Samboni, C; Giannakoulas, N; Symeonidis, A; Zoumbos, N
      Polyploidy in acute promyelocytic leukemia without the 15 : 17 translocation

      HAEMATOLOGICA
    19. Foley, R; Soamboonsrup, P; Carter, RF; Benger, A; Meyer, R; Walker, I; Wan, Y; Patterson, W; Orzel, A; Sunisloe, L; Leber, B; Neame, PB
      CD34-positive acute promyelocytic leukemia is associated with leukocytosis, microgranular/hypogranular morphology, expression of CD2 and bcr3 isoform

      AMERICAN JOURNAL OF HEMATOLOGY
    20. Pandolfi, PP
      Histone deacetylases and transcriptional therapy with their inhibitors

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    21. Savchenko, VG; Parovichnikova, EN; Isaev, VG; Demidova, IA; Olshanskaya, YV; Kucher, RA; Sokolov, AN; Ustinova, EN; Gribanova, EO; Pivnik, AV; Tikhonova, LY; Konstantinova, TS; Cherepanova, VV; Lapin, VA; Milyutina, GI; Zheltukhina, LN; Perekatova, TN; Belousov, EA; Filatov, LB; Obidina, NA; Tumakov, VA; Frolova, GL
      Acute promyelocytic leukemias: The epoch of new knowledge and advances

      GEMATOLOGIYA I TRANSFUZIOLOGIYA
    22. Deaglio, S; Mehta, K; Malavasi, F
      Human CD38: a (r)evolutionary story of enzymes and receptors

      LEUKEMIA RESEARCH
    23. Suzuki, H; Imaizumi, M; Sato, A; Yoshinari, M; Rikiishi, T; Endo, M; Takano, T; Shimizu, T; Hatae, Y; Fujimoto, T; Hayashi, Y; Iinuma, K
      Monitoring of minimal residual disease in children with acute promyelocytic leukemia by RT-PCR detecting PML/RAR alpha chimeric gene: A retrospectivestudy of clinical feasibility

      TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE
    24. Pepio, AM; Sossin, WS
      Membrane translocation of novel protein kinase Cs is regulated by phosphorylation of the C2 domain

      JOURNAL OF BIOLOGICAL CHEMISTRY
    25. Neufing, PJ; Shearwin, KE; Egan, JB
      Establishing lysogenic transcription in the temperate coliphage 186

      JOURNAL OF BACTERIOLOGY
    26. Rigolin, GM; Della Porta, M; Bigoni, R; Tieghi, A; Cuneo, A; Castoldi, G
      Dendritic cells in acute promyelocytic leukaemia

      BRITISH JOURNAL OF HAEMATOLOGY
    27. Virchis, A; Massey, E; Butler, T; Devaraj, P; Wright, F; Secker-Walker, L; Prentice, HG; Mehta, A
      Acute myeloblastic leukaemias of FAB types M6 and M4, with cryptic PML/RARalpha fusion gene formation, relapsing as acute promyelocytic leukaemia M3

      BRITISH JOURNAL OF HAEMATOLOGY
    28. Langabeer, SE; Rogers, JR; Harrison, G; Wheatley, K; Walker, H; Bain, BJ; Burnett, AK; Goldstone, AH; Linch, DC; Grimwade, D
      EVI1 expression in acute myeloid leukaemia

      BRITISH JOURNAL OF HAEMATOLOGY
    29. Pantic, M; Novak, A; Marisavljevic, D; Djordjevic, V; Elezovic, I; Vidovic, A; Colovic, M
      Additional chromosome aberrations in acute promyelocytic leukemia: characteristics and prognostic influence

      MEDICAL ONCOLOGY
    30. Gianni, M; Ponzanelli, I; Mologni, L; Reichert, U; Rambaldi, A; Terao, M; Garattini, E
      Retinoid-dependent growth inhibition, differentiation and apoptosis in acute promyelocytic leukemia cells. Expression and activation of caspases

      CELL DEATH AND DIFFERENTIATION
    31. Hara, T; Tsurumi, H; Yamada, T; Sawada, M; Moriwaki, H
      Detection of acute promyelocytic leukemia (APL) cells intermediately differentiated by all-trans retinoic acid in the cerebrospinal fluid: Central nervous system involvement in APL

      LEUKEMIA & LYMPHOMA
    32. Raanani, P; Segal, E; Levi, I; Bercowicz, M; Berkenstat, H; Avigdor, A; Perel, A; Ben-Bassat, I
      Diffuse alveolar hemorrhage in acute promyelocytic leukemia patients treated with ATRA - A manifestation of the basic disease or the treatment

      LEUKEMIA & LYMPHOMA
    33. Laczika, K; Mitterbauer, G; Weltermann, A; Knobl, P; Thalhammer-Scherrer, R; Haas, OA; Lechner, K; Jaeger, U
      Prolonged third remission in a patient with acute promyelocytic leukemia after consolidation chemotherapy with intermittent intermediate dose Ara-C and maintenance with intermittent all-trans retinoic acid (ATRA)

      LEUKEMIA & LYMPHOMA
    34. Wauben, MHM
      Immunological mechanisms involved in experimental peptide immunotherapy ofT-cell-mediated diseases

      CRITICAL REVIEWS IN IMMUNOLOGY
    35. Dhordain, P; Albagli, O; Honore, N; Guidez, F; Lantoine, D; Schmid, M; De The, H; Zelent, A; Koken, MHM
      Colocalization and heteromerization between the two human oncogene POZ/zinc finger proteins, LAZ3 (BCL6) and PLZF

      ONCOGENE
    36. Vannucchi, S; Percario, ZA; Chiantore, MV; Matarrese, P; Chelbi-Alix, MK; Fagioli, M; Pelicci, PG; Malorni, W; Fiorucci, G; Romeo, G; Affabris, E
      Interferon-beta induces S phase slowing via up-regulated expression of PMLin squamous carcinoma cells

      ONCOGENE
    37. Lai, HK; Borden, KLB
      The promyelocytic leukemia (PML) protein suppresses cyclin D1 protein production by altering the nuclear cytoplasmic distribution of cyclin D1 mRNA

      ONCOGENE
    38. Mizuno, R; Fujimoto, S; Fujimoto, T; Nishino, T; Shiiki, H; Hashimoto, T; Nakamura, S; Dohi, K
      Catastrophic antiphospholipid antibody syndrome in systemic lupus erythematosus: An autopsy case report of a young woman

      INTERNAL MEDICINE
    39. Bolognesi, E; Cimino, G; Diverio, D; Rapanotti, MC; D'Alfonso, S; Fleischhauer, K; Migliaretti, G; Momigliano-Richiardi, P
      HLA class I in acute promyelocytic leukemia (APL): possible correlation with clinical outcome

      LEUKEMIA
    40. Kinjo, K; Kizaki, M; Muto, A; Fukuchi, Y; Umezawa, A; Yamato, K; Nishihara, T; Hata, J; Ito, M; Ueyama, Y; Ikeda, Y
      Arsenic trioxide (As2O3)-induced apoptosis and differentiation in retinoicacid-resistant acute promyelocytic leukemia model in hGM-CSF-producing transgenic SCID mice

      LEUKEMIA
    41. Duprez, E; Benoit, G; Flexor, M; Lillehaug, JR; Lanotte, M
      A mutated PML/RARA found in the retinoid maturation resistant NB4 subclone, NB4-R2, blocks RARA and wild-type PML/RARA transcriptional activities

      LEUKEMIA
    42. Cassinat, B; Zassadowski, F; Balitrand, N; Barbey, C; Rain, JD; Fenaux, P; Degos, L; Vidaud, M; Chomienne, C
      Quantitation of minimal residual disease in acute promyelocytic leukemia patients with t(15;17) translocation using real-time RT-PCR

      LEUKEMIA
    43. Grolleau, A; Wietzerbin, J; Beretta, L
      Defect in the regulation of 4E-BP1 and 2, two repressors of translation initiation, in the retinoid acid resistant cell lines, NB4-R1 and NE4-R2

      LEUKEMIA
    44. So, CW; Dong, S; So, CKC; Cheng, GX; Huang, QH; Chen, SJ; Chan, LC
      The impact of differential binding of wild-type RAR alpha, PML-, PLZF- andNPM-RAR alpha fusion proteins towards transcriptional co-activator, RIP-140, on retinoic acid responses in acute promyelocytic leukemia

      LEUKEMIA
    45. Meyers, S; Hiebert, SW
      Alterations in subnuclear trafficking of nuclear regulatory factors in acute leukemia

      JOURNAL OF CELLULAR BIOCHEMISTRY
    46. Elbeialy, A; Strassburger-Lorna, K; Atsumi, T; Bertolaccini, ML; Amengual, O; Hanafi, M; Khamashta, MA; Hughes, GRV
      Antiphospholipid antibodies in leprotic patients: A correlation with disease manifestations

      CLINICAL AND EXPERIMENTAL RHEUMATOLOGY
    47. Wu, JS; Zhou, ZZ; Li, XP; Li, XM; Chen, YH; Wang, GS; Wang, ZY
      Activated protein C resistance in antiphospholipid thrombosis syndrome

      CHINESE MEDICAL JOURNAL
    48. Nakasaki, T; Wada, H; Mori, Y; Okugawa, Y; Watanabe, R; Nishikawa, M; Gabazza, EC; Masuya, M; Kageyama, S; Kumeda, K; Kato, H; Shiku, H
      Decreased tissue factor and tissue-plasminogen activator antigen in relapsed acute promyelocytic leukemia

      AMERICAN JOURNAL OF HEMATOLOGY
    49. Medvedeva, NA; Cherepanova, VV; Tarasova, LN; Kudryavtseva, AV; Kostin, AI; Kolupaeva, OR
      Change of hemostasis in the ATRA therapy of acute promyelocytic leukemia.

      GEMATOLOGIYA I TRANSFUZIOLOGIYA
    50. Medvedeva, NA; Cherepanova, VV; Tarasova, LN; Kudryavtseva, AV; Kosin, AI; Kolupaeva, OR
      Change of hemostasis in the ATRA therapy of acute promyelocytic leukemia

      TERAPEVTICHESKII ARKHIV
    51. Wiendl, H; Neuhaus, O; Kappos, L; Hohlfeld, R
      Multiple sclerosis: a current overview of failed and interrupted treatmenttrials

      NERVENARZT
    52. Samochocki, M; Zerlin, M; Jostock, R; Kormelink, PJG; Luyten, WHM; Albuquerque, EX; Maelicke, A
      Galantamine is an allosterically potentiating ligand of the human alpha 4/beta 2 nAChR

      ACTA NEUROLOGICA SCANDINAVICA
    53. Fabrizi, F; Sangiorgio, R; Pontoriero, G; Corti, M; Tentori, F; Troina, E; Locatelli, F
      Antiphospholipid (aPL) antibodies in end-stage renal disease

      JOURNAL OF NEPHROLOGY
    54. Levi, I; Raanani, P; Shalmon, B; Schiby-Brilliant, R; Ben-Bassat, I
      Acute neutrophilic dermatosis induced by all-trans-retinoic acid treatmentfor acute promyelocytic leukemia

      LEUKEMIA & LYMPHOMA
    55. Felice, MS; Rossi, J; Gallego, M; Zubizarreta, PA; Cygler, AM; Alfaro, E; Sackmann-Muriel, F
      Acute trilineage leukemia with monosomy of chromosome 7 following an acutepromyelocytic leukemia

      LEUKEMIA & LYMPHOMA
    56. Evans, GD; Grimwade, DJ
      Extramedullary disease in acute promyelocytic leukemia

      LEUKEMIA & LYMPHOMA
    57. Zong, S; Hu, P; Ye, TZ; Stan, R; Ellis, NA; Pandolfi, PP
      A role for PML and the nuclear body in genomic stability

      ONCOGENE
    58. Topcu, Z; Mack, DL; Hromas, RA; Borden, KLB
      The promyelocytic leukemia protein PML interacts with the proline-rich homeodomain protein PRH: a RING may link hematopoiesis and growth control

      ONCOGENE
    59. He, LZ; Merghoub, T; Pandolfi, PP
      In vivo analysis of the molecular pathogenesis of acute promyelocytic leukemia in the mouse and its therapeutic implications

      ONCOGENE
    60. Hummel, JL; Wells, RA; Dube, ID; Licht, JD; Kamel-Reid, S
      Deregulation of NPM and PLZF in a variant t(5;17) case of acute promyelocytic leukemia

      ONCOGENE
    61. Casini, T; Pelicci, PG
      A function of p21 during promyelocytic leukemia cell differentiation independent of CDK inhibition and cell cycle arrest

      ONCOGENE
    62. Hu, J; Shen, ZX; Sun, GL; Chen, SJ; Wang, ZY; Chen, Z
      Long-term survival and prognostic study in acute promyelocytic leukemia treated with all-trans-retinoic acid, chemotherapy, and As2O3: an experience of 120 patients at a single institution

      INTERNATIONAL JOURNAL OF HEMATOLOGY
    63. Uesugi, Y; Fuse, I; Toba, K; Kishi, K; Furukawa, T; Koike, T; Aizawa, Y
      Involvement of SHP-1, a phosphotyrosine phosphatase, during myeloid cell differentiation in acute promyelocytic leukemia cell lines

      EUROPEAN JOURNAL OF HAEMATOLOGY
    64. Zhu, J; Guo, WM; Yao, YY; Zhao, WL; Pan, L; Cai, X; Ju, B; Sun, GL; Wang, HL; Chen, SJ; Chen, GQ; Caen, J; Chen, Z; Wang, ZY
      Tissue factors on acute promyelocytic leukemia and endothelial cells are differently regulated by retinoic acid, arsenic trioxide and chemotherapeutic agents

      LEUKEMIA
    65. Gianni, M; de The, H
      In acute promyelocytic leukemia NB4 cells, the synthetic retinoid CD437 induces contemporaneously apoptosis, a caspase-3-mediated degradation of PML/RAR alpha protein and the PML retargeting on PML-nuclear bodies

      LEUKEMIA
    66. Girmenia, C; Latagliata, R; Tosti, S; Morano, SG; Celesti, F; Coppola, L; Spadea, A; Breccia, M; Battistini, R; Tafuri, A; Cimino, G; Mandelli, F; Alimena, G
      Outpatient management of acute promyelocytic leukemia after consolidation chemotherapy

      LEUKEMIA
    67. De Renzo, A; Santoro, LFE; Notaro, R; Pane, F; Buonaiuto, MR; Luciano, L; Rotoli, B
      Acute promyelocytic leukemia after treatment for non-Hodgkin's lymphoma with drugs targeting topoisomerase II

      AMERICAN JOURNAL OF HEMATOLOGY
    68. Brigati, C; Nobile, L; Fugazza, G; Zohouri, M; Gallagher, R; Cannizzaro, L
      A unique carboxy-terminus truncation mutant of the retinoic acid receptor alpha gene associated with a variant marker chromosome in a retinoic acid resistant HL-60 subline

      LEUKEMIA RESEARCH
    69. Yoshinari, M; Imaizumi, M; Sato, A; Minegishi, M; Fujii, K; Suzuki, H; Miura, T; Funato, T; Saito, T; Chikaoka, S; Rikiishi, T; Kizaki, M; Iinuma, K
      G-CSF induces apoptosis of a human acute promyelocytic leukemia cell line,UF-1: Possible involvement of Stat3 activation and altered Bax expression

      TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE
    70. Grimwade, D
      The pathogenesis of acute promyelocytic leukaemia: Evaluation of the role of molecular diagnosis and monitoring in the management of the disease

      BRITISH JOURNAL OF HAEMATOLOGY
    71. Allford, S; Grimwade, D; Langabeer, S; Duprez, E; Saurin, A; Chatters, S; Walker, H; Roberts, P; Rogers, J; Bain, B; Patterson, K; McKernan, A; Freemont, P; Solomon, E; Burnett, A; Goldstone, A; Linch, D
      Identification of the t(15;17) in AML FAB types other than M3: evaluation of the role of molecular screening for the PML/RAR alpha rearrangement in newly diagnosed AML

      BRITISH JOURNAL OF HAEMATOLOGY
    72. Di Noto, R; Boccuni, P; Costantini, S; Dello Russo, A; Lo Pardo, C; Copia, C; Annunziata, M; Cimino, R; Ferrara, F; Del Vecchio, L
      In vitro exposure of acute promyelocytic leukemia cells to arsenic trioxide (As2O3) induces the solitary expression of CD66c (NCA-50/90), a member ofthe CEA family

      TISSUE ANTIGENS
    73. HOBAN CJ
      RECENT ADVANCES IN PRECLINICAL DRUG DEVELOPMENT IN MULTIPLE-SCLEROSIS

      Expert opinion on therapeutic patents
    74. GARATTINI E; MOLOGNI L; PONZANELLI I; TERAO M
      CROSS-TALK BETWEEN RETINOIC ACID AND INTERFERONS - MOLECULAR MECHANISMS OF INTERACTION IN ACUTE PROMYELOCYTIC LEUKEMIA-CELLS

      Leukemia & lymphoma
    75. LITZ CE; ETZELL J
      ABERRANT DNA METHYLATION OF GENOMIC REGIONS TRANSLOCATED IN MYELOID MALIGNANCIES

      Leukemia & lymphoma
    76. VALLIAN S; GAKEN JA; GINGOLD EB; KOUZARIDES T; CHANG KS; FARZANEH F
      MODULATION OF FOS-MEDIATED AP-1 TRANSCRIPTION BY THE PROMYELOCYTIC LEUKEMIA PROTEIN

      Oncogene
    77. DAVID G; ALLAND L; HONG SH; WONG CW; DEPINHO RA; DEJEAN A
      HISTONE DEACETYLASE ASSOCIATED WITH MSIN3A MEDIATES REPRESSION BY THEACUTE PROMYELOCYTIC LEUKEMIA-ASSOCIATED PLZF PROTEIN

      Oncogene
    78. GELUK A; VANMEIJGAARDEN RE; ROEP BO; OTTENHOFF THI
      ALTERED PEPTIDE LIGANDS OF ISLET AUTOANTIGEN IMOGEN-38 INHIBIT ANTIGEN-SPECIFIC T-CELL REACTIVITY IN HUMAN TYPE-1 DIABETES

      Journal of autoimmunity (Print)
    79. TOBAL K; YIN JAL
      RT-PCR METHOD WITH INCREASED SENSITIVITY SHOWS PERSISTENCE OF PML-RARA FUSION TRANSCRIPTS IN PATIENTS IN LONG-TERM REMISSION OF APL

      Leukemia
    80. WELTERMANN A; PABINGER I; GEISSLER K; JAGER U; GISSLINGER H; KNOBL P; EICHINGER S; KYRLE PA; VALENT P; SPEISER W; SCHWARZINGER I; MANNHALTER C; LECHNER K
      HYPOFIBRINOGENEMIA IN NON-M3 ACUTE MYELOID-LEUKEMIA - INCIDENCE, CLINICAL AND LABORATORY CHARACTERISTICS AND PROGNOSIS

      Leukemia
    81. SANZ MA; DELARUBIA J; BONANAD S; BARRAGAN E; SEMPERE A; MARTIN G; MARTINEZ JA; JIMENEZ C; CERVERA J; BOLUFER P; SANZ GF
      PROLONGED MOLECULAR REMISSION AFTER PML RAR-ALPHA-POSITIVE AUTOLOGOUSPERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION IN ACUTE PROMYELOCYTIC LEUKEMIA - IS RELEVANT PRETRANSPLANT MINIMAL RESIDUAL DISEASE IN THE GRAFT/

      Leukemia
    82. TONG JH; FANT X; DUPREZ E; BENOIT G; UPHOFF CC; DREXLER HG; PLA JC; LOFVENBERG E; LANOTTE M
      EXPRESSION PATTERNS OF THE JEM-1 GENE IN NORMAL AND TUMOR-CELLS - UBIQUITY CONTRASTING WITH A FAINT, BUT RETINOID-INDUCED, MESSENGER-RNA EXPRESSION IN PROMYELOCYTIC NB4 CELLS

      Leukemia
    83. Parthasarathy, R; Mehta, K
      Altered metabolism of all-trans-retinoic acid in liposome-encapsulated form

      CANCER LETTERS
    84. TOBA K; AZEGAMI T; TSUKADA N; UESUGI Y; KISHI K; MASUKO M; NIWANO H; KOIKE T; TAKAHASHI H; MAEKAWA T; ABE T; AIZAWA Y
      HEMATOPOIETIC CYTOKINE-DEPENDENT DIFFERENTIATION TO EOSINOPHILS AND NEUTROPHILS IN A NEWLY ESTABLISHED ACUTE PROMYELOCYTIC LEUKEMIA-CELL LINE WITH T(15-17)

      Experimental hematology
    85. STROUD TWF; SYKES AM; WITT SF
      FORECASTING A COLLECTION OF BINOMIAL PROPORTIONS IN THE PRESENCE OF COVARIATES

      International journal of forecasting
    86. DEMEDEIROS BC; STRAPASSON E; PASQUINI R; DEMEDEIROS CR
      EFFECT OF ALL-TRANS-RETINOIC ACID ON NEWLY-DIAGNOSED ACUTE PROMYELOCYTIC LEUKEMIA PATIENTS - RESULTS OF A BRAZILIAN CENTER

      Brazilian journal of medical and biological research
    87. SAVCHENKO VG; PAROVICHNIKOVA EN; DEMIDOVA IA; KULIEV RG; GRIBANOVA EO; KLYASOVA GA; KUCHER RA; SOKOLOV AN; MOMOTYUK KS; OLSHANSKAYA YV; TYURINA NG; TIKHONOVA LY; GALSTYAN GM; BUDYANSKY VM; BELOUSOV EA; LAPIN VA; VOLOSHIN SV; KONSTANTINOVA TS; FILATOV LB; POROKHINA ON; SMIRNOVA EA
      BIOLOGICAL CHARACTERISTICS AND TREATMENT OF ACUTE PROMYELOCYTIC LEUKEMIA

      Terapevticeskij arhiv
    88. NAKHOST A; FORSCHER P; SOSSIN WS
      BINDING OF PROTEIN-KINASE-C ISOFORMS TO ACTIN IN APLYSIA

      Journal of neurochemistry
    89. GRIMWADE D; JAMAL R; GOULDEN N; KEMPSKI H; MASTRANGELO S; VEYS P
      SALVAGE OF PATIENTS WITH ACUTE PROMYELOCYTIC LEUKEMIA WITH RESIDUAL DISEASE FOLLOWING ABMT PERFORMED IN 2ND CR USING ALL-TRANS-RETINOIC ACID

      British Journal of Haematology
    90. FUJITA H; TOMIYAMA J; TANAKA T
      VITAMIN-K2 COMBINED WITH ALL-TRANS-RETINOIC ACID-INDUCED COMPLETE REMISSION OF RELAPSING ACUTE PROMYELOCYTIC LEUKEMIA

      British Journal of Haematology
    91. MARTINO B; VINCELLI I; MARINO A; COMIS M; RONCO F; NOBILE F
      MENINGEAL RELAPSE IN A PATIENT WITH ACUTE PROMYELOCYTIC LEUKEMIA TREATED WITH ALL-TRANS-RETINOIC ACID

      British Journal of Haematology
    92. CULLIGAN DJ; STEVENSON D; CHEE YL; GRIMWADE D
      ACUTE PROMYELOCYTIC LEUKEMIA WITH T(11-17)(Q23-Q12-21) AND A GOOD INITIAL RESPONSE TO PROLONGED ATRA AND COMBINATION CHEMOTHERAPY

      British Journal of Haematology
    93. GARATTINI E; FORTINO I; TERAO M
      MOLECULAR MECHANISMS OF RETINOID ACTION IN ACUTE PROMYELOCYTIC LEUKEMIA (REVIEW)

      International journal of oncology
    94. KURPAD AV; BORGONHA S; SHETTY PS
      MEASUREMENT OF TOTAL-ENERGY EXPENDITURE BY THE DOUBLY LABELED WATER TECHNIQUE IN FREE-LIVING INDIANS IN BANGALORE CITY

      INDIAN JOURNAL OF MEDICAL RESEARCH
    95. DAVID G; TERRIS B; MARCHIO A; LAVAU C; DEJEAN A
      THE ACUTE PROMYELOCYTIC LEUKEMIA PML-RAR-ALPHA PROTEIN INDUCES HEPATIC PRENEOPLASTIC AND NEOPLASTIC LESIONS IN TRANSGENIC MICE

      Oncogene
    96. VARGASALARCON G; YAMAMOTOFURUSHO JK; ZUNIGA J; CANOSO R; GRANADOS J
      HLA-DR7 IN ASSOCIATION WITH CHLORPROMAZINE-INDUCED LUPUS ANTICOAGULANT (LA)

      Journal of autoimmunity
    97. KIYOI H; NAOE T; YOKOTA S; NAKAO M; MINAMI S; KURIYAMA K; TAKESHITA A; SAITO K; HASEGAWA S; SHIMODAIRA S; TAMURA J; SHIMAZAKI C; MATSUE K; KOBAYASHI H; ARIMA N; SUZUKI R; MORISHITA H; SAITO H; UEDA R; OHNO R
      INTERNAL TANDEM DUPLICATION OF FLT3 ASSOCIATED WITH LEUKOCYTOSIS IN ACUTE PROMYELOCYTIC LEUKEMIA

      Leukemia
    98. XI ZF; RUSSELL M; WOODWARD S; THOMPSON F; WAGNER L; TAETLE R
      EXPRESSION OF THE ZN FINGER GENE, EVI-1, IN ACUTE PROMYELOCYTIC LEUKEMIA

      Leukemia
    99. ESTEY E; THALL P; KANTARJIAN H; PIERCE S; KORNBLAU S; KEATING M
      ASSOCIATION BETWEEN INCREASED BODY-MASS INDEX AND A DIAGNOSIS OF ACUTE PROMYELOCYTIC LEUKEMIA IN PATIENTS WITH ACUTE MYELOID-LEUKEMIA

      Leukemia
    100. KITAMURA K; KIYOI H; YOSHIDA H; TOBITA T; TAKESHITA A; OHNO R; NAOE T
      NEW RETINOIDS AND ARSENIC COMPOUNDS FOR THE TREATMENT OF REFRACTORY ACUTE PROMYELOCYTIC LEUKEMIA - CLINICAL AND BASIC STUDIES FOR THE NEXT-GENERATION

      Cancer chemotherapy and pharmacology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 30/10/20 alle ore 06:41:47